Company / Profit Margin
Akebia Therapeutics, Inc. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-2.3%
FY2025
5-year range
-83.5% / -2.3%
FY2021-FY2025
Trend
+94.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 8 years, ranging from -8843.5% in FY2018 to -2.3% in FY2025.
Based on SEC 10-K filings.
-2.3% in FY2025 with a 5-year CAGR of +66.9%.
Improved from -26.7% to -2.3% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +30.0pp
- 5-Year Change
- +66.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 94.8% year-over-year.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -2.3% | +94.8% |
| FY2024 | -43.3% | -62.4% |
| FY2023 | -26.7% | +17.2% |
| FY2022 | -32.2% | +61.4% |
| FY2021 | -83.5% | -20.8% |
| FY2020 | -69.1% | -70.0% |
| FY2019 | -40.6% | +99.5% |
| FY2018 | -8843.5% | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026